179 related articles for article (PubMed ID: 18218851)
1. Novel markers of normal and neoplastic human plasmacytoid dendritic cells.
Marafioti T; Paterson JC; Ballabio E; Reichard KK; Tedoldi S; Hollowood K; Dictor M; Hansmann ML; Pileri SA; Dyer MJ; Sozzani S; Dikic I; Shaw AS; Petrella T; Stein H; Isaacson PG; Facchetti F; Mason DY
Blood; 2008 Apr; 111(7):3778-92. PubMed ID: 18218851
[TBL] [Abstract][Full Text] [Related]
2. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm.
Dargent JL; Delannoy A; Pieron P; Husson B; Debecker C; Petrella T
J Cutan Pathol; 2011 Nov; 38(11):893-8. PubMed ID: 21883371
[TBL] [Abstract][Full Text] [Related]
4. Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.
Jaye DL; Geigerman CM; Herling M; Eastburn K; Waller EK; Jones D
Mod Pathol; 2006 Dec; 19(12):1555-62. PubMed ID: 16998465
[TBL] [Abstract][Full Text] [Related]
5. Plasmacytoid dendritic cell role in cutaneous malignancies.
Saadeh D; Kurban M; Abbas O
J Dermatol Sci; 2016 Jul; 83(1):3-9. PubMed ID: 27236509
[TBL] [Abstract][Full Text] [Related]
6. Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells.
Wang J; Lau KY; Jung J; Ravindran P; Barrat FJ
Eur J Immunol; 2014 Apr; 44(4):1130-6. PubMed ID: 24375473
[TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid dendritic cell expansion in myeloid neoplasms: A novel distinct subset of myeloid neoplasm?
Peng J; He S; Yang X; Huang L; Wei J
Crit Rev Oncol Hematol; 2023 Dec; 192():104186. PubMed ID: 37863402
[TBL] [Abstract][Full Text] [Related]
8. Cytologic features of blastic plasmacytoid dendritic cell neoplasm involving liver: A case report and literature review.
Ding Y; Yang J; Lindsey K
Diagn Cytopathol; 2021 Feb; 49(2):E80-E83. PubMed ID: 32852895
[TBL] [Abstract][Full Text] [Related]
9. Skin lesions in a patient with blastic plasmacytoid dendritic cell neoplasm.
Dlouhy I; Santacruz R; Peña O
Br J Haematol; 2014 Mar; 164(6):758. PubMed ID: 24372537
[No Abstract] [Full Text] [Related]
10. Increased plasmacytoid dendritic cells and RORγt-expressing immune effectors in cutaneous acute graft-versus-host disease.
Malard F; Bossard C; Brissot E; Chevallier P; Guillaume T; Delaunay J; Mosnier JF; Moreau P; Grégoire M; Gaugler B; Mohty M
J Leukoc Biol; 2013 Dec; 94(6):1337-43. PubMed ID: 23990625
[TBL] [Abstract][Full Text] [Related]
11. Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue.
Rizvi H; Paterson JC; Tedoldi S; Ramsay A; Calaminici M; Natkunam Y; Lonardi S; Tan SY; Campbell L; Hansmann ML; Jones D; Dikic I; Shaw AS; Pileri SA; Stein H; Mason DY; Facchetti F; Marafioti T
Pathologica; 2012 Apr; 104(2):56-64. PubMed ID: 22953501
[TBL] [Abstract][Full Text] [Related]
12. The MEK1/2-ERK Pathway Inhibits Type I IFN Production in Plasmacytoid Dendritic Cells.
Janovec V; Aouar B; Font-Haro A; Hofman T; Trejbalova K; Weber J; Chaperot L; Plumas J; Olive D; Dubreuil P; Nunès JA; Stranska R; Hirsch I
Front Immunol; 2018; 9():364. PubMed ID: 29535732
[TBL] [Abstract][Full Text] [Related]
13. Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation.
Hamadeh F; Awadallah A; Meyerson HJ; Beck RC
Cytometry B Clin Cytom; 2020 Jan; 98(1):43-51. PubMed ID: 30614203
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells.
Tsujimura H; Tamura T; Ozato K
J Immunol; 2003 Feb; 170(3):1131-5. PubMed ID: 12538667
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous CD4+ CD56+ hematologic malignancies.
Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
[TBL] [Abstract][Full Text] [Related]
16. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].
Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P
Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094
[TBL] [Abstract][Full Text] [Related]
17. CD4+ CD56+ hematodermic neoplasm and plasmacytoid dendritic cell tumor: case report and review of the literature.
Campbell SM; Moad JC; Sammons DL; Zirwas M
Cutis; 2012 Jun; 89(6):278-83. PubMed ID: 22838092
[TBL] [Abstract][Full Text] [Related]
18. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of human plasmacytoid dendritic cells.
Cao W
J Clin Immunol; 2009 May; 29(3):257-64. PubMed ID: 19266271
[TBL] [Abstract][Full Text] [Related]
20. Expressionof langerhans cell and plasmacytoid dendritic cell markers, and toll-like receptor 7/9 signaling pathway proteins in verruca vulgaris lesions.
Tang Y; Zhu X; Han R; Zhou Q; Cheng H
Medicine (Baltimore); 2020 Feb; 99(8):e19214. PubMed ID: 32080113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
